Skip to main content

Table 3 characteristics of radiotherapy alone group and radiotherapy combined with chemotherapy group after matching

From: Comparison of survival outcomes of locally advanced cervical cancer by histopathological types in the surveillance, epidemiology, and end results (SEER) database: a propensity score matching study

CharacteristicsRadiotherapy alone CTRT 
AC (n = 15)SCC(n = 15)P valueAC(n = 282)SCC(n = 282)P value
age (%)  0.833  0.901
  < 402 (13.3)2 (13.3)41 (14.5)41 (14.5) 
 40–495 (33.3)6 (40.1)98 (34.8)100 (35.5)
 50–594(26.7)2 (13.3)79 (28.0)84 (29.8) 
 60–694(26.7)5 (33.3)64 (22.7)57 (20.2) 
race (%)  0.648  0.969
 Black2 (13.3)4(26.7)27 (9.6)27 (9.6) 
 White13 (86.7)11 (73.3)36 (12.8)38 (13.5)
 Other0 (0.0)0 (0.0)219 (77.6)217 (76.9)
grade (%)  1.000  0.991
 I0 (0.0)0 (0.0) 33 (11.7)34 (12.1) 
 II4(26.7)5 (33.3)116 (41.1)114 (40.4)
 III11 (73.3)10 (66.7)124 (44.0)126 (44.7)
 IV0 (0.0)0 (0.0) 9 (3.2)8 (2.8) 
FIGO stage (%)  0.970  0.012
 Ib22 (13.3)1 (6.7) 45 (16.0)25 (8.9) 
 IIa11 (6.7)1 (6.7) 5 (1.8)5 (1.8) 
 IIa20 (0.0)1 (6.7) 11 (3.9)7 (2.5) 
 IIb2 (13.3)2 (13.3) 77 (27.3)68 (24.1) 
 IIIa1 (6.7)1 (6.7) 10 (3.5)9 (3.2) 
 IIIb7 (46.7)7 (46.7) 127 (45.0)146 (51.7)
 IVa2 (13.3)2 (13.3) 7 (2.5)22 (7.8) 
Radiation (%)  0.766  0.545
 Beam radiation11 (73.3)11 (73.3) 100 (35.5)91 (32.3) 
 brachytherapy2 (13.3)3 (20.0) 146 (51.7)159 (56.4)
 BRB2 (13.3)1 (6.7) 36 (12.8)32 (11.3) 
status (%)  1.000  0.542
 alive9 (60.0)9 (60.0)181 (64.2)173 (61.3)
 dead6(40.0)6(40.0) 101(35.8)109(38.7) 
time(mean(SD))40.4 (32.5)26.1(18.6)0.15033.5 (21.6)31.8 (22.5)0.353
  1. AC adenocarcinoma, SCC Squamous cell carcinoma, FIGO the International Federation of Gynecology and Obstetrics, BRB Combination of beam with brachytherapy. CTRT radiotherapy combined with chemotherapy, grade I Well differentiated,gradeII Moderately differentiated,gradeIII Poorly differentiated,gradeIV Undifferentiated;SD Standard Deviation